Top panels illustrate mechanisms of action: atropine (2.1 mg) competitively antagonizes acetylcholine at muscarinic receptors to reverse cholinergic effects (e.g., bronchorrhea, bronchospasm, bradycardia), while pralidoxime (2PAM, 600 mg) reactivates acetylcholinesterase by cleaving the nerve agentenzyme bond prior to irreversible aging. Middle panels depict the dualchamber autoinjector design, which contains atropine and pralidoxime in separate compartments and delivers both drugs sequentially via a springloaded intramuscular mechanism from a single needle
Natural Watermelon & Strawberry Flavour: Refreshing taste for easy daily consumption
Zhao Y, Lv H, Yu C, Liang J, Yu H, Du Z, Zhang R (2024) Systemic inhibition of mitochondrial fatty acid -oxidation impedes zebrafish ventricle regeneration
A mild stinging sensation is common with this compound because of its quinolinium chemistry